Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
29 hedge funds and large institutions have $39.3M invested in Global Cord Blood Corporation in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 3 closing their positions.
0.29% less ownership
Funds ownership: 9.64% → 9.35% (-0.29%)
8% less capital invested
Capital invested by funds: $42.7M → $39.3M (-$3.46M)
9% less funds holding
Funds holding: 32 → 29 (-3)
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$312K |
| 2 |
Renaissance Technologies
New York
|
+$165K |
| 3 |
GP
GLG Partners
London,
United Kingdom
|
+$121K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$55.9K |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$761K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$305K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$287K |
| 4 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
-$177K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$100K |
CO Hedge Fund Activity: Q2 2016 in Review
29 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2016, worth a combined $39.3M — down 8.1% from $42.7M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CO and 0 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 6 added.
The largest buyer was Credit Suisse, adding an estimated $312K. The largest seller was Citigroup, cutting an estimated $761K.
- 29 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2016, down from 32 in Q1 2016.
- Funds reported $39.3M of Global Cord Blood Corporation stock for Q2 2016, down 8.1% quarter-over-quarter.
- 0 funds opened new Global Cord Blood Corporation positions in Q2 2016 and 3 closed out, a net change of -3 holders.
- The largest Global Cord Blood Corporation buyer in Q2 2016 was Credit Suisse, an estimated $312K added.
- The largest Global Cord Blood Corporation seller in Q2 2016 was Citigroup, an estimated $761K sold.
Based on aggregated 13F filings for Q2 2016.